BiotechTube
EVQLV

EVQLV

New York, United States· Est.
evqlv.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $3.5M

Overview

EVQLV is a private, AI-driven biotech firm pioneering in silico antibody discovery to address inefficiencies in traditional drug development. Its core platform, powered by the HyperBind engine, rapidly generates and ranks millions of antibody sequences to identify high-affinity candidates against challenging targets like GPCRs. The company operates a platform-as-a-service business model, partnering with biopharma companies to rescue failing leads or design novel antibodies, positioning itself as an enabler in the rapidly growing computational drug discovery sector. EVQLV is pre-revenue and in a pre-clinical validation stage, focusing on platform development and strategic collaborations.

Antibodies

Technology Platform

Abtique platform powered by HyperBind, a sequence-driven AI engine for de novo design and optimization of fully-human therapeutic antibodies.

Funding History

1
Total raised:$3.5M
Seed$3.5M

Opportunities

The massive and growing therapeutic antibody market, combined with industry-wide pressure to reduce R&D costs and timelines, creates a strong demand for disruptive AI discovery platforms.
EVQLV can capitalize by securing fee-for-service and milestone-driven partnerships across the biopharma industry.

Risk Factors

Key risks include the failure of in silico designs to translate into functional antibodies in later-stage testing, intense competition from other AI-biotech firms, and a business model that may not capture the full financial upside of successful drug development.

Competitive Landscape

EVQLV competes in the AI-driven antibody discovery space with companies like Absci, BigHat Biosciences, LabGenius, and Atomwise. It differentiates with its HyperBind engine and focus on sequence-based de novo design. Large pharma companies are also developing internal AI capabilities, increasing competition.

More companies in AI / Machine Learning →More companies in United States →